Analyst firms · Raymond James · BAX

Raymond James BAX price target and rating history

Baxter International Inc. (BAX) · Health Care

Raymond James rates Baxter International Inc. (BAX) Mkt Perform with a $96 price target, as of its latest action on Jan 5, 2023. It has published 3 rating actions on BAX since January 2022, including 0 upgrades and 1 downgrade.

Current rating
Mkt Perform
Price target
$96
Median target, all firms
Too few
Actions on BAX
3

Raymond James price target on BAX

$99$98$962023202420252026
Raymond James price target on BAX, each point a stated target, January 2022 to February 2022.

Every Raymond James rating on BAX

How other firms rate BAX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchPeer PerformOct 20, 2026
BarclaysUnderweight$20Oct 7, 2026
CitigroupNeutral$28Jul 31, 2026

Questions about Raymond James and BAX

What is Raymond James's price target for BAX?
Raymond James's latest stated price target for Baxter International Inc. (BAX) is $96, from its action on Feb 18, 2022.
What is Raymond James's rating on BAX?
Raymond James rates BAX Mkt Perform, a neutral rating, as of Jan 5, 2023.
When did Raymond James last change its view on BAX?
On Jan 5, 2023, Raymond James downgrades to Mkt Perform from Outperform.

More BAX rating histories

All Raymond James ratingsBAX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.